Point Capital, Inc. Contracts & Agreements

Form of Lock-Up Agreement (Filed With SEC on July 22, 2024)

Form of Securities Purchase Agreement (Filed With SEC on July 22, 2024)

Form of Placement Agent Warrant (Filed With SEC on July 22, 2024)

Form of Warrant (Filed With SEC on July 22, 2024)

Exclusive License Agreement with Columbia University (Filed With SEC on July 8, 2024)

Fourth Amendment to Master License Agreement (Filed With SEC on June 27, 2024)

Form of Lock-Up Agreement (Filed With SEC on June 6, 2024)

Form of Securities Purchase Agreement (Filed With SEC on June 6, 2024)

Form of Placement Agent Warrant (Filed With SEC on June 6, 2024)

Form of Warrant (Filed With SEC on June 6, 2024)

Form of Pre-Funded Warrant (Filed With SEC on June 6, 2024)

Description of the Registrants Securities (Filed With SEC on March 25, 2024)

Third Amendment to Master License Agreement (Filed With SEC on November 14, 2023)

Description of the Registrants Securities (Filed With SEC on March 24, 2023)

First Amendment to Employment Agreement by and between the Company and Daniel Ryweck, dated October 12, 2022 (Filed With SEC on October 18, 2022)

Employment Agreement by and between the Company and Eric Weisblum, dated October 12, 2022 (Filed With SEC on October 18, 2022)

Form of First Amendment to Sponsored Research Agreement by and between the Company and Columbia University (Filed With SEC on October 18, 2022)

Ryweck Employment Agreement, dated September 28, 2022 (Filed With SEC on September 30, 2022)

Representatives Warrant, dated as of September 29, 2022 (Filed With SEC on September 30, 2022)

Underwriting Agreement by and between the Company and Laidlaw & Company (UK) Ltd., as representative of the several underwriters named therein dated September 26, 2022 (Filed With SEC on September 30, 2022)

Form of Underwriting Agreement (Filed With SEC on September 9, 2022)

Description of the Registrants Securities (Filed With SEC on March 28, 2022)

Form of Sponsored Research Agreement (Filed With SEC on October 27, 2021)

Form of Stock Purchase Agreement (Filed With SEC on September 27, 2021)

First Amendment to Commercial Evaluation and License Agreement, dated July 6, 2021, by and between the Company and UMB (Filed With SEC on July 12, 2021)

Sponsored Research Agreement, dated July 6, 2021, by and between the Company and UMB (Filed With SEC on July 12, 2021)

Sponsored Research Agreement, dated June 1, 2021, by and between the Company and UCSF (Filed With SEC on June 7, 2021)

Joint Venture Agreement, dated April 22, 2021, by and between the Company and Zyl Therapeutics, Inc (Filed With SEC on April 28, 2021)

Amendment No. 1 to Patent License Agreement, dated April 12, 2021, by and among the Company, Silo Pharma, Inc. and AIkido Pharma Inc (Filed With SEC on April 16, 2021)

Sublicense Agreement, dated April 6, 2021, by and between the Company and AIkido Pharma, Inc (Filed With SEC on April 7, 2021)

Description of the Registrants Securities (Filed With SEC on March 29, 2021)

Master License Agreement, dated February 12, 2021, by and between the Company and the University of Maryland, Baltimore (Filed With SEC on February 16, 2021)

Letter of Intent, dated February 12, 2021, by and between the Company and Aikido Pharma, Inc (Filed With SEC on February 16, 2021)

Form of Placement Agent Warrant (Filed With SEC on February 12, 2021)

Form of Registration Rights Agreement, dated as of February 9, 2021, between Silo Pharma, Inc. and the signatories thereto (Filed With SEC on February 10, 2021)

Form of Warrant (Filed With SEC on February 10, 2021)

Form of Securities Purchase Agreement, dated as of February 9, 2021, between Silo Pharma, Inc. and the signatories thereto (Filed With SEC on February 10, 2021)

Form of Lock-Up Agreement, dated as of February 9, 2021 (Filed With SEC on February 10, 2021)

First Amendment to Employment Agreement, dated January 18, 2021, by and between the Company and Eric Weisblum (Filed With SEC on January 28, 2021)

Silo Pharma, Inc. 2020 Omnibus Equity Incentive Plan (Filed With SEC on January 28, 2021)

Sponsored Research Agreement by and between the Company and the University of Maryland, Baltimore (Filed With SEC on January 11, 2021)

Patent License Agreement by and among the Company and Silo Pharma, Inc., a Florida corporation and their affiliates and subsidiaries and AIkido Pharma Inc (Filed With SEC on January 11, 2021)

Form of Registration Rights Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)

Form of Securities Purchase Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)

Form of Lock-Up Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)

Form of Exchange Agreement for Series B Preferred Stock, dated as of April 15, 2020 (Filed With SEC on April 22, 2020)

Form of Exchange Agreement for Convertible Notes, dated as of April 15, 2020 (Filed With SEC on April 22, 2020)

Form of Subscription Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)

Form of Consulting Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)

Form of Advisory Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)

Form of Employment Agreement, dated as of April 17, 2020 (Filed With SEC on April 22, 2020)

Form of Exchange Agreement for Convertible Notes, dated as of April 15, 2020 (Filed With SEC on April 21, 2020)

Form of Exchange Agreement for Series B Preferred Stock, dated as of April 15, 2020 (Filed With SEC on April 21, 2020)

Form of Subscription Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)

Form of Consulting Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)

Form of Advisory Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)

Form of Employment Agreement, dated as of April 17, 2020 (Filed With SEC on April 21, 2020)

Form of Securities Purchase Agreement for the purchase of Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on March 20, 2020)

Form of Warrant related to Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on March 20, 2020)

Form of registration rights agreement related to Series B preferred shares, dated November 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on March 20, 2020)

Form of Warrant (Filed With SEC on November 13, 2019)

Form of convertible note agreement with Investors (Filed With SEC on November 13, 2019)

Form of Securities Purchase Agreement, dated October 2019, between Uppercut Brands, Inc., and Investors (Filed With SEC on November 13, 2019)

Form of Return to Treasury Agreement (Filed With SEC on December 20, 2018)

Corrected Asset Purchase Agreement, dated September 28, 2018 (Filed With SEC on December 20, 2018)

Asset Purchase Agreement, dated September 28, 2018 (Filed With SEC on September 28, 2018)

Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (Filed With SEC on May 17, 2017)

CUSTODYAGREEMENT (Filed With SEC on November 14, 2014)

POINTCAPITAL, INC. CERTIFICATEOF DESIGNATION OF PREFERENCES, RIGHTSAND LIMITATIONS OF SERIESA CONVERTIBLE PREFERRED STOCK PURSUANTTO SECTION 151 OF THE DelawareGENERAL CORPORATION... (Filed With SEC on April 30, 2013)

SERIES A PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on April 30, 2013)

6% PROMISSORY NOTE (Filed With SEC on May 15, 2012)

Gold Swap Inc. Regulation D Subscription Agreement SECTION 1 (Filed With SEC on March 30, 2011)

Category

Industry

Companies

Contracts

Point Capital, Inc. Contracts & Agreements